Intermittent tamsulosin therapy in men with lower urinary tract symptoms

Journal of Urology

Volumn 173, Issue 1, 2005, Pages 155-157

  Yanardag, H ^a   Goktas, S ^a   Kibar, Y ^a   Kilic, S ^a   Erduran, D ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adrenergic alpha antagonists; Prostate; Prostatic hyperplasia; Tamsulosin; Urination disorders

Indexed keywords

TAMSULOSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG CAPSULE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOGRAPHY; GENERAL CONDITION IMPROVEMENT; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICTURITION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; RESIDUAL URINE; RETROGRADE EJACULATION; SCORING SYSTEM; URETHRA DISEASE; UROFLOWMETRY;

EID: 10344223529     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000146699.17331.19     Document Type: Article

References (13)

1. Kenny, B., Ballard, S., Blagg, J. and Fox, D.: Pharmacological options in the treatment of benign prostatic hyperplasia. J Med Chem, 40: 1293, 1997
2. Rossi, C., Kortmann, B. B., Sonke, G. S., Floratos, D. L., Kiemeney, L. A. L. M., Wijkstra, H. et al: α-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. J Urol, 165: 38, 2001
3. Schulman, C. C., Lock, T. M. T. W., Buzelin, J.-M., Boeminghaus, F., Stephenson, T. P., Talja, M. et al: Long-term use of tamsulosin to treat lower urinary tract symptoms/benign prostatic hyperplasia. J Urol, 166: 1358, 2001
4. Kaplan, S. A., Reis, R. B., Cologna, A., Suaid, H. J., Martins, A. C., Kohn, I. J. et al: Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptoms. Urology, 52: 12, 1998
5. De La Rosette, J. J. M. C. H., Kortmann, B. B. M., Rossi, C., Sonke, G. S., Floratos, D. L. and Kiemeney, L. A. L. M.: Long-term risk of re-treatment of patients using α-blockers for lower urinary tract symptoms. J Urol, 167: 1734, 2002
6. Pulito, V. L., Li, X., Varga, S. S., Mulcahy, L. S., Clark, K. S., Halbert, S. A., Reitz, A. B. et al: An investigation of the uroselective properties of four novel alpha(1a)-adrenergic receptor subtype-selective antagonists. J Pharmacol Exp Ther, 294: 224, 2000
7. Harada, K., Ohmori, M., Kitoh, Y., Sugimoto, K. and Fujimura, A.: A comparison of the antagonistic activities of tamsulosin and terazosin against human vascular alpha 1-adrenoceptors. Jpn J Pharmacol, 80: 209, 1999
8. Schulman, C. C., Cortvriend, J., Jonas, U., Lock, T. M., Vaage, S. and Speakman, M. J.: Tamsulosin: 3-year long-term efficacy and safety in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction: analysis of a European, multinational, multicenter, open-label study. European Tamsulosin Study Group. Eur Urol, 36: 609, 1999
9. Tsujii, T.: Comparison of prazosin, terazosin and tamsulosin in the treatment of symptomatic benign prostatic hyperplasia: a short-term open, randomized multicenter study. BPH Medical Therapy Study Group. Benign prostatic hyperplasia. Int J Urol, 7: 199, 2000
10. Ohtani, M., Kikuchi, K., Tsuchiya, A., Noguchi, R., Akaza, H. and Kondo, F.: A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of IPSS. Hinyokika Kiyo, 46: 791, 2000
11. Dunn, C. J., Matheson, A., and Faulds, D. M.: Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs Aging, 19: 135, 2002
12. Abrams, P., Speakman, M., Stott, M., Arkell, D. and Pocock, R.: A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective alpha1A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia). Br J Urol, 80: 587, 1997
13. Debruyne, F. M. J.: BPH symptoms do not return to baseline after withdrawal of terazosin. J Urol, suppl., 157: 252, abstract 986, 1997